Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guiding the process of health technology disinvestment.
Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Asua J. Ibargoyen-Roteta N, et al. Health Policy. 2010 Dec;98(2-3):218-26. doi: 10.1016/j.healthpol.2010.06.018. Epub 2010 Jul 17. Health Policy. 2010. PMID: 20638745
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL. Malmström RE, et al. Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013. Front Pharmacol. 2013. PMID: 23717279 Free PMC article.
Personalizing health care: feasibility and future implications.
Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL. Godman B, et al. BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. BMC Med. 2013. PMID: 23941275 Free PMC article. Review.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL. Godman B, et al. Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Front Pharmacol. 2014. PMID: 24959145 Free PMC article. Review.
Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country.
Ibargoyen-Roteta N, Mateos Del Pino M, Gutiérrez-Ibarluzea I, Benguria-Arrate G, Rada-Fernández de Jauregui D, Domingo-Rico C, Regidor Fuentes I, González Santisteban R, Armendáriz Cuñado M, Jaio Atela N. Ibargoyen-Roteta N, et al. GMS Health Technol Assess. 2018 Nov 5;14:Doc01. doi: 10.3205/hta000130. eCollection 2018. GMS Health Technol Assess. 2018. PMID: 31015866 Free PMC article.
81 results